Strontium citrate is a dietary supplement that pairs the mineral strontium with citric acid to form a salt your body can absorb. It is marketed primarily for bone health, and its appeal rests on strontium’s unusual ability to both encourage new bone formation and slow bone breakdown. That dual action sounds almost too good to be true, and the reality is complicated. Most of the strong clinical evidence for strontium’s bone benefits comes from a different compound, strontium ranelate, which was a prescription drug in Europe. The leap from ranelate to citrate involves assumptions that matter for anyone considering this supplement.
What Strontium Is and Why It Ends Up in Bone
Strontium is a naturally occurring element that sits just below calcium on the periodic table, which means the two behave similarly in your body. Your bones cannot easily tell them apart. When you ingest strontium, a small fraction gets incorporated into bone mineral by swapping in where calcium normally sits. This happens at a roughly one-to-one exchange ratio at the crystal level, and it is this chemical similarity that drives both strontium’s potential benefits and its complications.
The citrate part of strontium citrate is simply the delivery vehicle. Citric acid is a common, well-absorbed organic acid found in citrus fruits. Binding strontium to citrate makes the mineral easier for your gut to take up compared to some other forms. Other strontium compounds exist: strontium ranelate (a pharmaceutical), strontium chloride (used in some toothpastes), and strontium carbonate. The strontium ion itself is the active ingredient regardless of what it is paired with, which is why research on strontium ranelate gets invoked in discussions about strontium citrate supplements. Whether that extrapolation is justified is one of the central questions around this product.
How Strontium Affects Bone Cells
Strontium’s mechanism of action has attracted scientific interest for three decades because it does something unusual: it simultaneously promotes the activity of osteoblasts (the cells that build new bone) and inhibits osteoclasts (the cells that break bone down).1Bone Reports. A review of the latest insights into the mechanism of action of strontium in bone Most osteoporosis drugs do one or the other. Bisphosphonates, for instance, primarily slow bone breakdown. Parathyroid hormone analogs primarily stimulate bone building. Strontium appears to do both, which is what makes it appealing on paper.
The way strontium pulls this off involves the calcium-sensing receptor on bone cells. Because strontium mimics calcium, it activates this receptor and triggers downstream signaling that nudges osteoblasts to ramp up their work.2PubMed Central. The Influence of Strontium on Bone Tissue Metabolism and Its Application in Osteoporosis Treatment Lab studies have shown increases in markers associated with bone formation, including alkaline phosphatase, osteocalcin, and collagen production. At the same time, strontium appears to dampen signals that activate osteoclasts, slowing the rate at which old bone gets removed.
The Evidence Gap Between Ranelate and Citrate
Here is where things get tricky for supplement shoppers. The large, well-designed clinical trials that demonstrated real fracture reduction were all conducted with strontium ranelate, a pharmaceutical that was available by prescription in Europe and other countries but was never approved in the United States. In one major trial involving women with postmenopausal osteoporosis, strontium ranelate reduced the risk of new vertebral fractures by about 41% over three years compared to placebo.3PubMed. The effects of strontium ranelate on the risk of vertebral fracture in women with postmenopausal osteoporosis Another large trial found it cut vertebral fracture risk by roughly 39% and reduced the risk of major non-vertebral fractures by about 19%.4PubMed. Strontium ranelate reduces the risk of nonvertebral fractures in postmenopausal women with osteoporosis: Treatment of Peripheral Osteoporosis (TROPOS) study Additional analysis confirmed these benefits held across different baseline risk levels, with about a 40% reduction in vertebral fractures and a 15% reduction in non-vertebral fractures overall.5PubMed. Vertebral fracture risk reduction with strontium ranelate in women with postmenopausal osteoporosis is independent of baseline risk factors
Those are meaningful numbers. The problem is that strontium citrate, the supplement form sold over the counter, has never been tested in trials of comparable size or rigor. The assumption that citrate delivers the same benefits rests on the idea that the strontium ion is doing the work regardless of what it is attached to. That is plausible from a chemistry standpoint, but plausible is not proven. Drug regulators generally require evidence for the specific formulation being sold, and strontium citrate has not cleared that bar. When you see supplement marketing citing the fracture-reduction numbers above, it is worth knowing those numbers belong to a different product.
The Bone Density Measurement Problem
This is the issue that frustrates researchers and misleads patients more than any other aspect of strontium supplementation. Standard bone density scans (DXA scans) work by measuring how much X-ray energy bone absorbs. Strontium absorbs X-rays more strongly than calcium does. So when strontium gets incorporated into your bone, your DXA results look better than they actually are.6PubMed. Effect of bone strontium on BMD measurements
The math on this overestimation is startling. For every 1% of bone calcium that gets replaced by strontium, DXA-measured bone density is overestimated by about 10%.7Journal of Nutrition Health & Food Science. Change in Bone Mineral Density with Strontium Citrate: An Illusion or Reality That means if you are taking strontium citrate and your doctor orders a DXA scan, the results may show an impressive jump in bone density that partly reflects the presence of a heavier element rather than genuinely stronger bone. This does not mean strontium provides zero benefit, but it does mean that DXA scans alone cannot tell you how much of the improvement is real and how much is an artifact of having strontium in your skeleton.
For anyone using strontium citrate and tracking their bone health, this is a practical headache. You and your doctor cannot simply take a DXA result at face value. Some researchers have tried to develop correction formulas to account for strontium’s influence on scans, but these require knowing how much strontium has actually been incorporated into your bone, which is not something a standard clinical visit can determine easily.
Cardiovascular Risks and the Ranelate Story
Strontium ranelate’s regulatory history in Europe provides a cautionary tale. After years on the market, safety reviews flagged an increased risk of blood clots and a possible signal for heart attacks. Pooled data from randomized trials showed a higher rate of non-adjudicated heart attacks in patients taking strontium ranelate compared to placebo, with roughly 60% greater odds.8PubMed Central. Cardiac concerns associated with strontium ranelate European regulators responded by restricting the drug’s use to patients with severe osteoporosis who could not take other treatments and who had no history of cardiovascular disease.
The picture is not entirely clear-cut, though. A broader review of cardiovascular safety across minerals noted that while strontium ranelate is associated with increased risk of thromboembolic disease (blood clots in veins), the heart attack signal is not consistently supported when wider data are considered.9PubMed Central. Cardiovascular safety of calcium, magnesium and strontium: what does the evidence say? The blood clot risk, however, appears more consistent.
An important question is whether these cardiovascular concerns apply to strontium citrate as well. If the strontium ion itself is responsible for the cardiac effects, then the citrate form would carry the same risks. If the ranelic acid portion of the molecule contributed to the problem, then citrate might be safer. The honest answer is that nobody knows for certain, because strontium citrate has not been studied in large enough populations to detect rare cardiovascular events. People with existing heart disease or a history of blood clots should be especially cautious, and discussing strontium citrate use with a cardiologist is reasonable before starting.
Allergic and Skin Reactions
One of the more alarming adverse effects documented with strontium is a severe allergic-type reaction called DRESS syndrome (drug reaction with eosinophilia and systemic symptoms). This involves a widespread rash, fever, and organ involvement, and it can be life-threatening if not caught early. DRESS has been identified as a recognized adverse reaction to strontium ranelate, and guidelines emphasize that any rash appearing during treatment should lead to immediate and permanent discontinuation.10Osteoporosis International. Drug rash with eosinophilia and systemic symptoms (DRESS) in patients receiving strontium ranelate
A case report has documented DRESS syndrome occurring specifically with strontium citrate supplementation as well, confirming this is not exclusively a ranelate problem.11JAAD Case Reports. Strontium citrate associated drug reaction with eosinophilia and systemic symptoms syndrome with granulomatous dermatitis DRESS is rare, but its severity means anyone starting strontium citrate should know what to watch for. If you develop a rash, fever, or swollen lymph nodes within the first few weeks of starting the supplement, stop taking it and seek medical attention promptly.
How Strontium Citrate Compares to Standard Osteoporosis Drugs
Even setting aside the ranelate-versus-citrate evidence gap, strontium is not at the top of the osteoporosis treatment hierarchy. A comparative analysis found that several other medications produced greater fracture risk reductions than strontium ranelate, including alendronate, risedronate, zoledronate, and denosumab.12PubMed Central. New strategies for osteoporosis patients previously managed with strontium ranelate These are all prescription medications with robust trial data behind them.
There is also a sequencing issue. Research suggests that if you have previously taken bisphosphonates (like alendronate or risedronate), switching to strontium ranelate produces a blunted response. In one study, people who had never taken bisphosphonates saw a 5.6% increase in spine bone density after a year on strontium ranelate. Those who had previously used bisphosphonates saw only a 2.1% increase at the spine and no change at the hip, and they actually experienced more vertebral fractures.13PubMed. The effect of prior bisphosphonate therapy on the subsequent BMD and bone turnover response to strontium ranelate The likely explanation is that bisphosphonates suppress bone turnover for months after stopping, and strontium’s mechanism depends on active bone remodeling to exert its effects. If you are considering strontium citrate after coming off a bisphosphonate, the transition may not produce the results you expect.
Animal Data on Different Strontium Forms
One area where strontium citrate has been directly studied is in animal models comparing different strontium salts head to head. In a study using ovariectomized mice (a standard model for postmenopausal bone loss), researchers compared strontium ranelate, strontium citrate, and strontium chloride. All three forms increased cortical bone mineral density compared to untreated controls. However, strontium citrate produced the lowest increase in cortical bone density among the three forms. It also resulted in the lowest strontium content in bone mineral and the lowest cancellous bone tissue mineral density of the strontium groups.14PMC (National Institutes of Health / MDPI). Influence of Various Strontium Formulations (Ranelate, Citrate, and Chloride) on Bone Mineral Density, Morphology, and Microarchitecture: A Comparative Study in an Ovariectomized Female Mouse Model of Osteoporosis – Section: Bone Mineral Density of the Trabecular and Cortical Bones
This is only one mouse study, so it is far from definitive. But it is worth noting because it complicates the assumption that all strontium salts are interchangeable. If strontium citrate is less effectively incorporated into bone than strontium ranelate or chloride, as this study suggests, then extrapolating the ranelate trial data to citrate becomes even more questionable.
Can Too Much Strontium Interfere with Calcium?
The relationship between strontium and calcium is cooperative at low strontium doses but antagonistic at high ones. Classic animal research demonstrated that when the calcium-to-strontium ratio in blood dropped below about 10 to 1, strontium began interfering with normal bone mineralization. Rats fed escalating levels of strontium developed signs resembling rickets: widened growth plates, uncalcified bone tissue, and reduced mineral content in bone.15Australasian Annals of Medicine. Strontium “rickets”: Bone, calcium and strontium changes
In practical terms for supplement users, this means adequate calcium intake is not optional when taking strontium citrate. If your calcium intake is low and your strontium intake is high, you could shift the ratio in a direction that harms rather than helps your bones. Most strontium citrate supplement labels recommend taking the supplement at a different time of day than calcium, because the two compete for absorption in the gut. That timing advice is reasonable, but it also means you need to be deliberate about getting enough calcium from your overall diet to maintain a healthy ratio.
Pregnancy Considerations
A prenatal toxicity study in rats tested strontium citrate specifically at escalating doses. At the two lower doses tested, there were no differences in fetal weight, sex ratio, resorption, or stillbirth compared to controls. At the highest dose, however, researchers observed bone and eye abnormalities in fetuses.2PubMed Central. The Influence of Strontium on Bone Tissue Metabolism and Its Application in Osteoporosis Treatment Rat studies do not translate directly to human pregnancy, but the finding that very high strontium citrate doses caused skeletal anomalies in developing animals is enough reason for pregnant women to avoid strontium supplements. Since the primary target audience for strontium citrate is postmenopausal women, this is not usually a practical conflict, but younger women with bone concerns should know about it.
Strontium’s Role in Dental Health
Outside of bone, strontium has attracted interest for its effects on tooth enamel. Strontium ions can substitute into hydroxyapatite, the mineral that makes up tooth enamel, in a similar way to how they integrate into bone. Research has explored whether this exchange could protect against enamel erosion and promote remineralization of early cavities.
In a randomized trial comparing different remineralization treatments for white spot lesions on teeth after orthodontic brackets were removed, a strontium-doped nano-hydroxyapatite paste performed significantly better than a standard casein phosphopeptide-amorphous calcium phosphate cream.16PubMed Central. Remineralization potential of strontium-doped nano-hydroxyapatite dentifrice and casein phosphopeptide-amorphous calcium phosphate cream on white spot lesions in enamel following orthodontic debonding – a randomized controlled trial Lab studies have also found that the presence of strontium in solution slows the rate at which calcium and phosphorus dissolve from enamel under acidic conditions, essentially offering a protective buffer against acid erosion.17Future Foods. Strontium and enamel hydroxyapatite stability: Exploring strontium potential as a food supplement
Strontium’s dental applications are still largely experimental and are delivered topically rather than through oral supplements. Strontium chloride has been used in desensitizing toothpastes for years, and newer formulations incorporating strontium into bioactive dental materials are under active development.18PubMed Central. Yellow light and ultrasound Dual-responsive strontium-doped zinc oxide composites for dental caries prevention and remineralization Whether taking strontium citrate as an oral supplement provides any meaningful dental benefit is unclear, since the concentrations reaching your teeth through the bloodstream would be far lower than what is used in topical applications.
How Strontium Leaves Your Body
Strontium is eliminated primarily through the kidneys. Measurements in patients receiving radioactive strontium (a different medical context involving cancer treatment, not supplementation) showed that renal clearance accounts for the vast majority of strontium removal from the blood, with a smaller contribution from the gut.19European Journal of Nuclear Medicine. Measurements of the strontium plasma clearance rate in patients receiving 89Sr radionuclide therapy The practical takeaway is that people with impaired kidney function will clear strontium more slowly, leading to higher levels building up in the body. If your kidneys are not working well, strontium citrate supplementation carries additional risk of accumulation, and the potential for calcium interference and bone mineralization problems increases accordingly.
What Supplement Labels Will Not Tell You
Because strontium citrate is sold as a dietary supplement in the United States and Canada, it is not subject to the same regulatory scrutiny as prescription drugs. Manufacturers do not need to prove it works before selling it. They cannot legally claim it treats osteoporosis, but they can use softer language like “supports bone health,” which many consumers reasonably interpret as the same thing.
The typical supplement dose ranges from about 340 mg to 680 mg of elemental strontium per day, which is considerably lower than the 680 mg of elemental strontium delivered daily in the strontium ranelate clinical trials (the total ranelate dose was 2 grams, but much of that weight is the ranelic acid carrier). Whether lower doses provide proportionally lower benefits is unknown. There is no dose-response curve established for strontium citrate in human fracture prevention, because the necessary trials have not been done.
Supplement quality is another variable. Independent testing has occasionally found that strontium citrate products contain different amounts of elemental strontium than their labels claim. Without pharmaceutical-grade manufacturing standards and oversight, batch-to-batch consistency is not guaranteed. If you choose to use strontium citrate, selecting a product that carries a third-party testing seal from an organization like USP, NSF, or ConsumerLab adds a layer of verification that the contents match the label.